Smooth AdCom Passage Expected For Novo's Semaglutide Despite Retinopathy Queries

 
• By Lucie Ellis-Taitt
  
Monorail
Novo's semaglutide is speeding towards US launch before end of 2017 • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas